🔍
Search Results - evelina+angov
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
A Malaria Vaccine Based on CH-rPfs 48/45 Antigen and Adjuvant Formulations to Stop Malaria Transmission
C10497: A Malaria Vaccine to Stop Malaria Transmission Technical Details: Malaria is a disease caused by parasites of the genus Plasmodium. It affects near 2 billion people worldwide and results in 1-2 million deaths every year. Transmission-blocking vaccines (TBV) have received attention as potentially effective strategy in the fight against malaria....
Published: 3/13/2025
|
Inventor(s):
Evelina Angov
,
Nirbhay Kumar
Keywords(s):
Adjuvant
,
Biologics
,
Disease Indication
,
Infectious Diseases
,
Malaria
,
Parasitic Infections
,
Single
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
,
Therapy Type
,
Vaccine
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Infectious Diseases > Malaria
,
Clinical and Disease Specializations > Infectious Diseases > Parasitic Infections
,
Technology Classifications > Therapeutic Modalities
,
Technology Classifications > Therapeutic Modalities > Biologics
,
Technology Classifications > Therapeutic Modalities > Vaccines
,
Clinical and Disease Specializations > Infectious Diseases
A p105-based NF-(kappa) B Super repressor
C04290: A p105-based NF-(kappa) B Super repressor Technical Details: Nuclear factor (NF)-kB is a family of transcription factors that regulate immune and inflammatory responses, programmed cell death (apoptosis), and developmental processes. In normal cells, NF-kB is latent, and is activated transiently by stimuli and stresses. However, under pathological...
Published: 3/13/2025
|
Inventor(s):
Li Lin
Keywords(s):
Biologics
,
Cancers
,
Chemotherapy
,
Disease Indication
,
Nucleic Acid
,
Single
,
Skin Cancer
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
,
Therapy Type
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Dermatology
,
Clinical and Disease Specializations > Oncology > Skin Cancer
,
Technology Classifications > Therapeutic Modalities > Gene Therapies
,
Technology Classifications > Therapeutic Modalities > Proteins
,
Technology Classifications > Therapeutic Modalities > Targets
,
Clinical and Disease Specializations > Oncology
,
Technology Classifications > Therapeutic Modalities
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum